Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma 2 Jul Written by Carla Aguilera Balaguer J, García Hidalgo L, Hladun R, Márquez Vega C, Pérez Alonso V. Target Oncol. 2023 Jan;18(1):77-93. doi: 10.1007/s11523-022-00930-w. Epub 2022 Dec 12. PMID: 36504394; PMCID: PMC9928814. 2023 Carla Aguilera Previous Previous Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results.... Next Next Optimising urinary catecholamine metabolite diagnostics for neuroblastoma
Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma 2 Jul Written by Carla Aguilera Balaguer J, García Hidalgo L, Hladun R, Márquez Vega C, Pérez Alonso V. Target Oncol. 2023 Jan;18(1):77-93. doi: 10.1007/s11523-022-00930-w. Epub 2022 Dec 12. PMID: 36504394; PMCID: PMC9928814. 2023 Carla Aguilera
